BioCryst Pharmaceuticals ...

8.39
0.17 (2.07%)
At close: Apr 25, 2025, 3:59 PM
8.40
0.06%
After-hours: Apr 25, 2025, 05:49 PM EDT

BioCryst Pharmaceuticals Revenue

BioCryst Pharmaceuticals reported an annual revenue of $450.71M, reflecting a 36% growth. For the quarter ending December 31, 2024, BioCryst Pharmaceuticals generated $131.53M in revenue.
Revenue (ttm)
$450.71M
Revenue Growth
36%
Price / Sales Ratio
3.45
Revenue / Employee
$777.09K
Employees
580
Market Cap
1.75B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 450.71M +36.00%
Dec 31, 2023 331.41M +22.37%
Dec 31, 2022 270.83M +72.31%
Dec 31, 2021 157.17M +782.38%
Dec 31, 2020 17.81M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.